OneChain Immunotherapeutics: Funding, Investors & Team (Sep 2026)
OneChain Immunotherapeutics is a separate company that originated from the Josep Carreras Leukemia Research Institute and ICREA. Its main objective is to utilize Dr. Pablo Menéndez's expertise to create CAR-T candidates targeting various antigens. These candidates are intended to provide a treatment option for hematological malignancies.
OneChain Immunotherapeutics has raised $7.4M across 1 funding round on record, the most recent a Seed of $7.4M announced in Jun 2023.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
OneChain Immunotherapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2023.
OneChain Immunotherapeutics Funding Rounds
OneChain Immunotherapeutics Founders and Leadership Team
Contact details for the OneChain Immunotherapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →OneChain Immunotherapeutics Funding Compared to Other Biotechnology Startups
OneChain Immunotherapeutics' latest round of $7.4M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like OneChain Immunotherapeutics in Biotechnology and Barcelona
Companies Similar to OneChain Immunotherapeutics
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…
IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…
Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…
Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…
Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…
Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
OneChain Immunotherapeutics Funding FAQs
What does OneChain Immunotherapeutics do?
OneChain Immunotherapeutics is a separate company that originated from the Josep Carreras Leukemia Research Institute and ICREA. Its main objective is to utilize Dr. Pablo Menéndez's expertise to create CAR-T candidates targeting various antigens. These candidates are intended to provide a treatment option for hematological malignancies.
How much funding has OneChain Immunotherapeutics raised?
OneChain Immunotherapeutics has raised $7.4M across 1 round on record. The most recent is a Seed of $7.4M announced in Jun 2023.
When did OneChain Immunotherapeutics last raise funding?
OneChain Immunotherapeutics' most recent funding round on record is a Seed of $7.4M, announced in Jun 2023.
Who founded OneChain Immunotherapeutics?
FundedIQ lists Pablo Menendez (Founder) at OneChain Immunotherapeutics.
Where is OneChain Immunotherapeutics headquartered?
OneChain Immunotherapeutics is based in Barcelona, Catalonia, Spain.
How many employees does OneChain Immunotherapeutics have?
OneChain Immunotherapeutics is in the 1-10 employee band.
How does OneChain Immunotherapeutics' funding compare to other Biotechnology startups?
OneChain Immunotherapeutics' latest round of $7.4M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's OneChain Immunotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OneChain Immunotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.